November 20th 2024
While a large retrospective study found that interstitial lung abnormalities (ILAs) were evident on 1.7 percent of computed tomography (CT) scans, researchers found that 43.9 percent of ILAs, including fibrotic ILAs, were not reported.
Siemens Healthineers Get FDA Nod for New SPECT/CT Scanner
June 12th 2022The newly FDA-cleared Symbia Pro.specta SPECT/CT Scanner, which reportedly offers a variety of enhanced capabilities including low-dose CT up to 64 slices and intuitive workflow guides, was launched at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting.
Study Suggests the COVID-19 Pandemic Led to Millions of Decreased Cancer Screenings
June 6th 2022A new survey study from the American Cancer Society shows a 4.47 million decrease in cervical cancer screenings and a 2.13 million decrease in breast cancer screenings in the United States between 2018 and 2020.
Can Diffusion-Weighted MRI Have an Impact in Detecting Recurrent Pancreatic Cancer?
May 29th 2022For post-op monitoring of patients who had pancreatic ductal adenocarcinoma (PDAC) resection, a new study showed that diffusion-weighted magnetic resonance imaging (MRI) had enhanced sensitivity for detecting recurrent tumors in comparison to conventional MRI.
AI May Bolster Assessment of Pulmonary Nodules on Chest CT
May 24th 2022A new study revealed that an emerging artificial intelligence (AI)-enabled software tool led to improved sensitivity, specificity and inter-observer agreement for the diagnosis of indeterminate pulmonary nodules on chest computed tomography (CT) scans.
Iodinated Contrast Media: 15 Recommendations for Addressing the Shortage
May 12th 2022Given the challenges with the shortage of the iodinated contrast agent Omnipaque, national and state organizations have issued suggested risk mitigation and conservation strategies to reprioritize imaging needs during this temporary shortage.
New Study Shows Impact of COVID-19 and Comorbidities in Inner-City Lung Screening Cohort
May 1st 2022In a lung screening cohort of over 2,500 people, researchers found that significantly higher rates of chronic kidney disease and chronic heart failure were associated with increased hospitalization and mortality rates in patients with COVID-19.
ACR Urges CMS to Reconsider Non-Coverage of Computed Tomography Colonography (CTC)
April 7th 2022In a formal request to the Centers for Medicare and Medicaid Services (CMS), the American College of Radiology (ACR) emphasized that Medicare and Medicaid coverage of computed tomography colonography (CTC) could significantly improve colorectal cancer screening rates for at-risk populations.
CMS Expands Medicare Eligibility for CT Lung Cancer Screening
February 15th 2022In a new national coverage determination, the Centers for Medicare and Medicaid Services (CMS) have lowered the starting thresholds for lung cancer screening from 55 to 50 years of age and from a 30-pack/year tobacco smoking history to 20 packs a year.